The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
Newsletter Oct 2017
Topics include Partnerships with African initiatives, Co-infections and co-morbidities; Research capacity development; Calls & grants. Subscribe here.
Session at ASTMH
Join the EDCTP (booth 425) & Wellcome Trust symposium on Clinical trials in pregnancy | Session 130 |08/11/2017, 08:00-09:45 |Room 341/342
EU action against antimicrobial resistance: EDCTP’s contribution
Antimicrobial resistance and improper use of antibiotics are a potential global threat to healthcare. During the European Antibiotic Awareness Week…
GSK and EDCTP launch joint call for Senior Fellowship proposals
In response to the growing challenge of non-communicable diseases (NCDs) in Africa, GSK and EDCTP will launch a joint call…